Aspidospermine is an indole alkaloid with biological properties associated with combating parasites included in the genera
Plasmodium, Leishmania and
Trypanossoma. The present study evaluated the cytotoxicity (resazurin test), genotoxicity (comet assay) and mechanism of action (gene expression analysis via qRT-PCR) of this alkaloid in human HepG2 cells. The results demonstrated that treatment with aspidospermine was both cytotoxic (starting at 75 μM) and genotoxic (starting at 50 μM). There was no significant modulation of the expression of the following genes:
GSTP1 and
GPX1 (xenobiotic metabolism);
CAT (oxidative stress);
TP53 and
CCNA2 (cell cycle);
HSPA5,
ERN1,
EIF2AK3 and
TRAF2 (endoplasmic reticulum stress);
CASP8, CASP9, CASP3, CASP7, BCL-
2, BCL-
XL BAX and
BAX (apoptosis); and
PCBP4, ERCC4, OGG1, RAD21 and
MLH1 (DNA repair). At a concentration of 50 μM (non-cytotoxic, but genotoxic), there was a significant increase in the expression of
CYP1A1 (xenobiotic metabolism) and
APC (cell cycle), and at a concentration of 100 μM, a significant increase in the expression of
CYP1A1 (xenobiotic metabolism),
GADD153 (endoplasmic reticulum stress) and
SOD (oxidative stress) was detected, with repression of the expression of
GR (xenobiotic metabolism and oxidative stress). The results of treatment with aspidospermine at a 100 μM concentration (the dose indicated in the literature to achieve 89 % reduction of the growth of
L. amazonensis) suggest that increased oxidative stress and an unfolded protein response (UPR) occurred in HepG2 cells. For the therapeutic use of aspidospermine (antiparasitic), chemical alteration of the molecule to achieve a lower cytotoxicity/genotoxicity in host cells is recommended.